Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.34 |
---|---|
High | 9.34 |
Low | 9.34 |
Bid | 8.95 |
Offer | 9.72 |
Previous close | 9.32 |
Average volume | 333.33 |
---|---|
Shares outstanding | 160.97m |
Free float | 120.45m |
P/E (TTM) | -- |
Market cap | 1.57bn USD |
EPS (TTM) | -0.1944 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:11 GMT.
More ▼
Announcements
- Certara Reports Third Quarter 2024 Financial Results
- Certara to Participate in the Stephens Annual Investment Conference
- Certara Appoints John Reynders as New Independent Board Member
- Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
- Certara Completes Acquisition of Chemaxon
- Certara’s Simcyp Consortium Celebrates 25th Anniversary
- Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
- Certara to Participate in Upcoming Investor Conferences
- Certara Launches Phoenix™ Version 8.5 Drug Development Software
- Certara Reports Second Quarter 2024 Financial Results
More ▼